Expand RARE Menu
RARE MENU

RARE Stock Posts


RARE #UltragenyxPharmaceutical stock declines -7.4% in premarket,

Premarket Decliner

RARE Ultragenyx Pharmaceutical47.00-3.70-7.3%

Premarket:43.50-3.50 (-7.5%)

Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatment with GTX-102

Globe NewswireMon, 15-Apr 7:00 AM
Upcoming Earnings

RARE Ultragenyx Pharmaceutical46.47+0.81 (+1.8%)

Ultragenyx Pharmaceutical will report earnings after the market closes. View Calendar The market is expecting a ±5.7% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±7.1%. View Expected Move (Conf Call: Feb 15 5:00 PM)
Unusual Option Volume

RARE Ultragenyx Pharmaceutical45.61-0.30 (-0.7%)

Ultragenyx Pharmaceutical trades 2,629 contracts.
View Details...
Upcoming Earnings

RARE Ultragenyx Pharmaceutical36.69+0.65 (+1.8%)

Ultragenyx Pharmaceutical will report earnings after the market closes. View Calendar The market is expecting a ±9.3% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±7.0%. View Expected Move (Conf Call: Nov 2 5:00 PM)
RARE #UltragenyxPharmaceutical stock declines -5.5% in after hours trading. See the latest news.

After Hours Decliner

RARE Ultragenyx Pharmaceutical36.83-0.19-0.5%

After Hours:34.80-2.03 (-5.5%)

Ultragenyx Announces Proposed Public Offering of Common Stock

Globe NewswireTue, 17-Oct 4:02 PM
RARE #UltragenyxPharmaceutical stock declines -5.5% in after hours trading. See the latest news.

After Hours Decliner

RARE Ultragenyx Pharmaceutical36.83-0.19-0.5%

After Hours:34.80-2.03 (-5.5%)

Ultragenyx Announces Proposed Public Offering of Common Stock

Globe NewswireTue, 17-Oct 4:02 PM
Load Earlier Posts